Fruquintinib

3 trials 3 recruiting LOncology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

2 Sponsors

4 Countries

Phase III

Phase II

Phase III: 1 Phase II: 2

Sponsors using this IMP

Fondation Franc.Cancerologie Digestive 2 Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH 1

All trials

3 total

PRODIGE 115 (FFCD 2406) ULYSSE : FOLFOX/FOLFIRI + Bévacizumab ou Fruquintinib en 2ème ligne du Cancer Colorectal métastatique (CCRm) : essai… Recruiting

2025-522108-26-00 Phase II 1 country Fondation Franc.Cancerologie Digestive
ENGIC 06 (PRODIGE 114) – FFCD 2401 – FRUQUITAS Randomized phase III trial to compare trifluridine/tipiracil + Fruquintinib versus triflurid… Recruiting

2025-522395-92-00 Phase III 3 countries Fondation Franc.Cancerologie Digestive
– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Profici… Recruiting

2024-519929-38-00 Phase II 2 countries Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Showing 1–3 of 3 trials

← All drugs A–Z